NEW YORK, May 16 Medicsight PLC, a subsidiary ofMGT Capital Investments, Inc. (Amex: MGT) (the "Company"), and an industryleader in the development of Computer-Aided Detection (CAD) and image analysissoftware which assists in the early detection and diagnosis of disease, todayannounced the appointment of NM Rothschild & Sons Limited ("Rothschild"), aleading international investment bank, as corporate adviser to the Company,effective immediately.
Rothschild has been appointed by Medicsight to offer independent adviceand help to develop corporate opportunities. As stated in the Company's AIMAdmission document, one of Medicsight's objectives over the next one to twoyears is to seek strategic merger and acquisition opportunities in order tointroduce additional products into its portfolio.
Tim Paterson-Brown, MGT Chairman and CEO, stated, "We are pleased toannounce the appointment of Rothschild, and welcome their independent andstrategic advice. They have a strong healthcare team in place, with which welook forward to building a long and successful working relationship.
"In order to take advantage of the tremendous opportunities our existingtechnologies offer, we are required to have an experienced and knowledgeableteam in place. We are confident that Rothschild will prove to be oftremendous value to our Company in building upon our existing technologies andidentify new opportunities."
In addition, Medicsight announced the appointment of Nomura CodeSecurities Limited as Nominated Adviser (NOMAD) and sole broker to the Companyeffective immediately.
"Our Board is impressed by Nomura Code's market knowledge and specialistinvestor contacts within the healthcare sector. Nomura Code also hassignificant outreach in Japan, which will be very beneficial to Medicsight aswe penetrate the Asian market and continue to develop a strong relationshipwith Toshiba," concluded Mr. Paterson-Brown.
About MGT Capital Investments, Inc.
MGT Capital Investments, Inc is a holding company that focuses oninvestments in the global healthcare information technology market. TheCompany has two subsidiaries, Medicsight PLC and Medicexchange PLC.
Medicsight PLC (AIM: MDST) is a leading developer of computer-aideddetection (CAD) software solutions. Medicsight's CAD solutions help cliniciansutilizing Computed Tomography (CT) scans to identify, measure and analyzesuspicious pathology within the colon and lungs. The Medicsight CAD productsare validated against one of the world's largest databases of verified CT scandata collected from leading healthcare institutions from around the world.Medicsight products allow radiologists and physicians to review scans morequickly and accurately -- saving both time and lives.
Medicexchange PLC provides medical imaging professionals with a global webportal containing an online sales, jobs and information channel fordiagnostic, treatment and surgery planning solutions. This combined with avariety of relevant clinical papers, training materials and content givesthese professionals access to information and products that they otherwisewould have difficulty accessing.
Additional information can be found at www.mgtci.com.
All forward-looking statements are made pursuant to the 'safe harbor'provisions of the Private Securities Litigation Reform Act of 1995.Forward-looking statements are based on current management expectations thatinvolve risks and uncertainties that may result in such expectations not beingrealized. Potential risks and uncertainties include, but are not limited to,the risks described in company filings with the Securities and ExchangeCommission.
SOURCE MGT Capital Investments, Inc.